Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Center for Salivary and Rare Head and Neck Cancers offers a range of clinical therapeutic trials focusing on particular salivary and rare cancer subtypes, or novel pathways of interest with relevance to these conditions.
While some trials may overlap with other tumor types, our Center aims to centralize trials of interest, and to serve as a gateway to personalizing the therapeutic approach for each patient.
New Patient Appointments